Go to deals
Consumer & Retail | Healthcare | Private Equity

C.B. Fleet Company, Inc. has been acquired by Prestige Brands Holdings, Inc.

C.B. Fleet Company, Inc. (Fleet Laboratories), a portfolio company of Gryphon Investors, has been sold to Prestige Brands Holdings, Inc. Financial details have not been disclosed.

C.B. Fleet Company, also known as Fleet Laboratories, manufactures and markets consumer health, beauty, and over-the-counter pharmaceutical products for consumers and healthcare professionals worldwide. It offers gastrointestinal care products for bowel cleansing, and relief of constipation and gas symptoms, feminine health and hygiene products, and infant care products.

Prestige Brands is the largest independent provider of over-the-counter products in North America providing detailed attention to each and every one of its product offerings. Prestige is constantly improving, creating products that match the ever-changing lifestyles and needs of people and families everywhere.

Founded in 1995 and based in San Francisco, Gryphon Investors focuses on leveraged acquisitions of, and growth investments in, middle-market companies in partnership with experienced management teams. With more than US$1.4 billion of cumulative equity commitments, Gryphon has an extensive track record of investing up to US$100 million of its committed capital per investment in companies with sales ranging from approximately US$100 to 500 million.

One of Oaklins' teams in the USA served as financial advisor to C.B. Fleet Company, a portfolio company of Gryphon Investors, in its sale to Prestige Brands.

Service
M&A sell-side
Parties

Talk to the deal team

 W. Gregory  Robertson

W. Gregory Robertson

Managing Director

New York, United States
Oaklins TM Capital

Related deals

Permali Gloucester has been acquired by Diamorph (subject to regulatory approval)
Private Equity | Aerospace & Defense | Automotive | Industrial Machinery & Components

Permali Gloucester has been acquired by Diamorph (subject to regulatory approval)

Private equity firm 3i Group and the private shareholders of Permali Gloucester Limited have sold their interest in the company to Diamorph.

Learn more
BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher
Private Equity | Other Industries

BaltCap has sold Labochema to French laboratory supply distributor Dominique Dutscher

BaltCap Lithuania SME Fund has sold its 46% shareholding in Labochema UAB, a Lithuanian laboratory supplies trading company, to Dominique Dutscher. Labochema’s CEO and the chairman also sold their shareholdings. As a result of the transaction, Dominique Dutscher now controls 100% of Labochema.

Learn more
VækstPartner Kapital and founders and management sell CIM Industrial Systems to XANO
Private Equity | TMT

VækstPartner Kapital and founders and management sell CIM Industrial Systems to XANO

VækstPartner Kapital and the founders and management of the leading pharma/industry 4.0 production software specialist CIM Industrial Systems A/S have sold the company to the listed Swedish group XANO Industri AB.

Learn more